AMOTL1 and hepatocellular carcinoma: Mechanistically, we demonstrated that, in HCC cells, administration of Tankyrase inhibitors increases AMOTL1 and AMOTL2 protein expression, leading to decreased YAP protein levels and transcriptional activity.